ISRCTN53369512已完成未知
Medical Research Council/ European Blood and Marrow Transplant Prospective Randomised Trial of Autograft in Chronic Myeloid Leukaemia (CML)
Medical Research Council (MRC) (UK)0 个研究点目标入组 0 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Newly diagnosed Ph-positive and/or breakpoint cluster region (BCR)-abelson (ABL) positive CML
- •2. Aged 15-65
- •3 .Chronic phase disease
- •4. No contraindication to the collection of peripheral blood progenitor cells before commencing treatment
- •5. No major organ impairment
- •6. No pregnancy
排除标准
- •Not provided at time of registration.
研究者
相似试验
已完成
不适用
A joint MRC/European Organisation for Research and Treatment of Cancer (EORTC) study of radiotherapy for low grade astrocytomas and oligodendrogliomasCancerISRCTN17931175Medical Research Council (MRC) (UK)250
进行中（未招募）
1 期
Clinical trial for the treatment of COVID-19 and COVID-like illness in primary careCOVID-19, COVID-like-illnessMedDRA version: 21.1Level: PTClassification code: 10068724Term: Antiviral treatment Class: 100000004865CTIS2022-501707-27-01niversity Medical Center Utrecht1,001
进行中（未招募）
不适用
Clinical trial for the treatment of COVID-19 and COVID-like illness in primary careReducing illness duration, complications, and possibly transmission of COVID-19 (SARS-CoV-2 infection) and other respiratory pathogensInfections and InfestationsISRCTN55471843niversity Medical Center Utrecht1,700
招募中
不适用
European register for rare vascular diseasesrare vascular diseasesDRKS00033512niversitätsklinikum Heidelberg5,000
招募中
不适用
eurooncological register studyC71Malignant neoplasm of brainDRKS00033855eurologische Klinik, Universitätsklinikum Heidelberg3,000